Two-time cancer survivor Sherman McDaniel may be in fragile health, but she is sticking to her vow: “I’m not going anywhere until Generic Theater has a permanent home. Until then, I will not die.” ...

A drug that helped turn Novo Nordisk into Europe's most valuable company is about to lose its monopoly grip across much of the globe. Patent protections on semaglutide—sold as Ozempic for diabetes and ...

MUMBAI: Natco Pharma has heralded what could become an intense pricing war in India’s pharmaceutical sector by offering its generic version of semaglutide at 90% cheaper than the original weight-loss ...

All the Indian generics are substantially cheaper – the prices vary between Rs 1,300 and Rs 4,500 per month - than the original ones.

The Democratic Party continues to lead over Republicans in the battle to control the House of Representatives, but by a slimmer margin than two months ago. The latest Rasmussen Reports national ...

At least a dozen large Indian drugmakers are set to roll out copies of Novo Nordisk A/S’s blockbuster weight-loss drugs as soon as the patent expires Friday, crashing prices in the country with the ...

President Donald Trump, who is in the midst of pressuring senators to curb the use of mail-in voting, voted by mail ballot in Tuesday’s special election in Palm Beach County, Florida. The Palm Beach ...

Multiple domestic pharmaceutical companies launched generic semaglutide on Saturday, a day after the drug's patent expired in India, with prices falling by as much as 90% from the branded version, ...

Alkem’s semaglutide pen devices will be marketed under the brand names Semasize, Obesema, and Hepaglide. Alkem Laboratories is positioning itself to lead India’s fast-growing weight-loss drug market, ...

BENGALURU -- Ameya Nagarajan forks out nearly 25,000 rupees ($270) every month for weight-loss drugs, 20% more than the average monthly income of a salaried Indian.

Did our AI summary help? Novo Nordisk on Tuesday slashed prices of its blockbuster diabetes and obesity drugs Ozempic and Wegovy in India, to defend its hold after the launch of multiple low-cost ...